The Contribution of Hypertensive Disorders of Pregnancy to Late Preterm and Term Admissions to Neonatal Units in the UK 2012-2020 and Opportunities to Avoid Admission: A Population-based Study Using the National Neonatal Research Database

Overview

Journal BJOG

Specialty Gynecology & Obstetrics

Date 2023 Jun 20

PMID 37337344

Authors

Frances Conti-Ramsden

Jessica Fleminger

Julia Lanoue

Lucy C Chappell

Cheryl Battersby

Affiliations

Soon will be listed here.

Abstract

Objective: To quantify maternal hypertensive disorder of pregnancy (HDP) prevalence in late preterm and term infants admitted to neonatal units (NNU) and assess opportunities to avoid admissions.

Design: A retrospective population-based study using the National Neonatal Research Database.

Setting: England and Wales.

Population: Infants born ≥34 weeks' gestation admitted to NNU between 2012 and 2020.

Methods: Outcomes in HDP infants are compared with non-HDP infants using regression models.

Main Outcome Measures: Hypertensive disorder of pregnancy, primary reason for admission, clinical diagnoses and resource use.

Results: 16 059/136 220 (11.8%) of late preterm (34 to 36 weeks' gestation) and 14 885/284 646 (5.2%) of term (≥37 weeks' gestation) admitted infants were exposed to maternal HDP. The most common primary reasons for HDP infant admission were respiratory disease (28.3%), prematurity (22.7%) and hypoglycaemia (16.4%). HDP infants were more likely to be admitted with primary hypoglycaemia than were non-HDP infants (odds ratio [OR] 2.1, 95% confidence interval [CI] 2.0-2.2, P < 0.0001). 64.5% of HDP infants received i.v. dextrose. 35.7% received mechanical or non-invasive ventilation. 8260/30 944 (26.7%) of HDP infants received intervention for hypoglycaemia alone (i.v. dextrose) with no other major intervention (respiratory support, parenteral nutrition, central line, arterial line or blood transfusion).

Conclusions: The burden of maternal HDP on late preterm and term admissions to NNU is high, with hypoglycaemia and respiratory disease being the main drivers for admission. Over one in four were admitted solely for management of hypoglycaemia. Further research should determine whether maternal antihypertensive agent choice or postnatal pathways may reduce NNU admission.

Citing Articles

The interdependence of mid-trimester blood pressure and glucose levels in shaping fetal growth and neonatal outcomes: implications for risk-benefit assessment and co-management.

Lv L, Yang J, Li L, Huang C, Shi H, Fang Y BMC Med. 2025; 23(1):161.

PMID: 40087732 DOI: 10.1186/s12916-025-03990-7.

The Contribution of Hypertensive Disorders of Pregnancy to Neonatal Unit Admissions and Iatrogenic Preterm Delivery at < 34 Weeks' Gestation in the UK: A Population-Based Study Using the National Neonatal Research Database.

Conti-Ramsden F, Fleminger J, Lanoue J, Chappell L, Battersby C BJOG. 2024; 132(3):306-317.

PMID: 39370603 PMC: 11704029. DOI: 10.1111/1471-0528.17976.

Trends in the Incidence of Hypertensive Disorders of Pregnancy Among the Medicaid Population before and During COVID-19.

Lin J, Feng H, Horswell R, Chu S, Shen Y, Hu G Womens Health Rep (New Rochelle). 2024; 5(1):641-649.

PMID: 39346805 PMC: 11424987. DOI: 10.1089/whr.2024.0045.

Pharmacotherapeutic options for the treatment of hypertension in pregnancy.

Conti-Ramsden F, de Marvao A, Chappell L Expert Opin Pharmacother. 2024; 25(13):1739-1758.

PMID: 39225514 PMC: 11881908. DOI: 10.1080/14656566.2024.2398602.

Trends of hypertensive disorders of pregnancy among the Medicaid population before and during COVID-19.

Hu G, Lin J, Feng H, Horswell R, Chu S, Shen Y Res Sq. 2023; .

PMID: 38077001 PMC: 10705593. DOI: 10.21203/rs.3.rs-3616259/v1.

References

Battersby C, Michaelides S, Upton M, Rennie J . Term admissions to neonatal units in England: a role for transitional care? A retrospective cohort study. BMJ Open. 2017; 7(5):e016050. PMC: 5726072. DOI: 10.1136/bmjopen-2017-016050. View

Webster L, Conti-Ramsden F, Seed P, Webb A, Nelson-Piercy C, Chappell L . Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017; 6(5). PMC: 5524099. DOI: 10.1161/JAHA.117.005526. View

Levene I, Wilkinson D . Identification and management of neonatal hypoglycaemia in the full-term infant (British Association of Perinatal Medicine-Framework for Practice). Arch Dis Child Educ Pract Ed. 2018; 104(1):29-32. DOI: 10.1136/archdischild-2017-314050. View

Battersby C, Statnikov Y, Santhakumaran S, Gray D, Modi N, Costeloe K . The United Kingdom National Neonatal Research Database: A validation study. PLoS One. 2018; 13(8):e0201815. PMC: 6095506. DOI: 10.1371/journal.pone.0201815. View

Uquillas K, Lee R, Sardesai S, Chen E, Ihenacho U, Cortessis V . Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. J Perinatol. 2020; 40(9):1339-1348. DOI: 10.1038/s41372-020-0589-1. View

Abalos E, Duley L, Steyn D, Gialdini C . Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018; 10:CD002252. PMC: 6517078. DOI: 10.1002/14651858.CD002252.pub4. View

Cole T, Donaldson M, Ben-Shlomo Y . SITAR--a useful instrument for growth curve analysis. Int J Epidemiol. 2010; 39(6):1558-66. PMC: 2992626. DOI: 10.1093/ije/dyq115. View

Hibbard J, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M . Respiratory morbidity in late preterm births. JAMA. 2010; 304(4):419-25. PMC: 4146396. DOI: 10.1001/jama.2010.1015. View

Buchbinder A, Sibai B, Caritis S, MacPherson C, Hauth J, Lindheimer M . Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002; 186(1):66-71. DOI: 10.1067/mob.2002.120080. View

10.

Dassios T, Greenough A, Leontiadi S, Hickey A, Kametas N . Admissions for hypoglycaemia after 35 weeks of gestation: perinatal predictors of cost of stay. J Matern Fetal Neonatal Med. 2017; 32(3):448-454. DOI: 10.1080/14767058.2017.1381905. View

11.

Conti-Ramsden F, Fleminger J, Lanoue J, Chappell L, Battersby C . The contribution of hypertensive disorders of pregnancy to late preterm and term admissions to neonatal units in the UK 2012-2020 and opportunities to avoid admission: A population-based study using the National Neonatal Research Database. BJOG. 2023; 131(1):88-98. PMC: 10767760. DOI: 10.1111/1471-0528.17574. View

12.

Steegers E, von Dadelszen P, Duvekot J, Pijnenborg R . Pre-eclampsia. Lancet. 2010; 376(9741):631-44. DOI: 10.1016/S0140-6736(10)60279-6. View

13.

Fitton C, Steiner M, Aucott L, Pell J, Mackay D, Fleming M . In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017; 35(11):2123-2137. PMC: 5625961. DOI: 10.1097/HJH.0000000000001456. View

14.

Webbe J, Duffy J, Afonso E, Al-Muzaffar I, Brunton G, Greenough A . Core outcomes in neonatology: development of a core outcome set for neonatal research. Arch Dis Child Fetal Neonatal Ed. 2019; 105(4):425-431. PMC: 7363790. DOI: 10.1136/archdischild-2019-317501. View

15.

McElwee E, Wilkinson K, Crowe R, Hardy K, Newman J, Chapman A . Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemia. Am J Obstet Gynecol MFM. 2022; 4(5):100687. DOI: 10.1016/j.ajogmf.2022.100687. View

16.

Webster L, Bramham K, Seed P, Homsy M, Widdows K, Webb A . Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study. Ultrasound Obstet Gynecol. 2018; 54(1):72-78. DOI: 10.1002/uog.20132. View

17.

Flacking R, Lehtonen L, Thomson G, Axelin A, Ahlqvist S, Moran V . Closeness and separation in neonatal intensive care. Acta Paediatr. 2012; 101(10):1032-7. PMC: 3468719. DOI: 10.1111/j.1651-2227.2012.02787.x. View

18.

Deshmukh M, Patole S . Antenatal corticosteroids for impending late preterm (34-36+6 weeks) deliveries-A systematic review and meta-analysis of RCTs. PLoS One. 2021; 16(3):e0248774. PMC: 7984612. DOI: 10.1371/journal.pone.0248774. View

19.

Langenveld J, Ravelli A, van Kaam A, van der Ham D, van Pampus M, Porath M . Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry. Am J Obstet Gynecol. 2011; 205(6):540.e1-7. DOI: 10.1016/j.ajog.2011.07.003. View

20.

Gibbins K, Silver R, Pinar H, Reddy U, Parker C, Thorsten V . Stillbirth, hypertensive disorders of pregnancy, and placental pathology. Placenta. 2016; 43:61-8. PMC: 5893308. DOI: 10.1016/j.placenta.2016.04.020. View